CN Patent

CN102245171A — 缓释微粒及其制备方法

Assigned to Amorepacific Corp · Expires 2011-11-16 · 15y expired

What this patent protects

本发明涉及缓释微粒，其包括：包含药理学活性组分的基质；以及缓释层，所述缓释层包含在基质上形成缓释膜的物质。本发明的缓释微粒不仅允许对药物双重释放的有效的控制，而且还可以表现出优异的溶解特性，即使当使用少量包衣物质时也是如此。

USPTO Abstract

本发明涉及缓释微粒，其包括：包含药理学活性组分的基质；以及缓释层，所述缓释层包含在基质上形成缓释膜的物质。本发明的缓释微粒不仅允许对药物双重释放的有效的控制，而且还可以表现出优异的溶解特性，即使当使用少量包衣物质时也是如此。

Drugs covered by this patent

Patent Metadata

Patent number: CN102245171A
Jurisdiction: CN
Classification: —
Expires: 2011-11-16
Drug substance claim: No
Drug product claim: No
Assignee: Amorepacific Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.